| Drug dosing in obese adults M Barras, A Legg Australian prescriber 40 (5), 189, 2017 | 124 | 2017 |
| Outcomes of patients with a history of injecting drug use and receipt of outpatient antimicrobial therapy K O’Callaghan, S Tapp, K Hajkowicz, A Legg, KL McCarthy European Journal of Clinical Microbiology & Infectious Diseases 38, 575-580, 2019 | 18 | 2019 |
| Evidence of clinical response and stability of ceftolozane/tazobactam used to treat a carbapenem-resistant Pseudomonas aeruginosa lung abscess on an outpatient antimicrobial … A Stewart, JA Roberts, SC Wallis, AM Allworth, A Legg, KL McCarthy International Journal of Antimicrobial Agents 51 (6), 941-942, 2018 | 12 | 2018 |
| Beta-lactam dose optimisation in the intensive care unit: targets, therapeutic drug monitoring and toxicity A Legg, S Carmichael, MG Chai, JA Roberts, MO Cotta Antibiotics 12 (5), 870, 2023 | 11 | 2023 |
| Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial A Legg, N Meagher, SA Johnson, MA Roberts, A Cass, MH Scheetz, ... Clinical drug investigation 43 (1), 23-33, 2023 | 7 | 2023 |
| Study protocol: Australasian registry of severe cutaneous adverse reactions (AUS-SCAR) F James, MSY Goh, E Mouhtouris, S Vogrin, KYL Chua, NE Holmes, ... BMJ open 12 (8), e055906, 2022 | 7 | 2022 |
| Plasma concentrations resulting from continuous infusion of meropenem in a community-based outpatient program: A case series A Legg, M Halford, K McCarthy American Journal of Health-System Pharmacy 77 (24), 2074-2080, 2020 | 7 | 2020 |
| Early Oral Antibiotic Switch in Staphylococcus aureus Bacteraemia: The Staphylococcus aureus Network Adaptive Platform (SNAP) Trial Early Oral Switch Protocol D de Kretser, J Mora, M Bloomfield, A Campbell, MP Cheng, S Guy, ... Clinical infectious diseases, ciad666, 2023 | 6 | 2023 |
| Contemporaneous management of ampicillin infusions in the outpatient setting through the use of therapeutic drug monitoring F Parsonson, A Legg, M Halford, K McCarthy International journal of antimicrobial agents 55 (6), 105975, 2020 | 6 | 2020 |
| Improving palliative and supportive care in advanced cirrhosis: the HepatoCare model of integrated collaborative care A Kearney, N Tiwari, O Cullen, A Legg, I Arbi, C Douglas, B Leggett, ... Internal Medicine Journal 53 (11), 1963-1971, 2023 | 2 | 2023 |
| Oral antivirals for mild–moderate COVID-19: a panacea or a logistical and clinical conundrum? ID Coombes, A Legg, T Patterson, T Kelly, A Henderson, JA Roberts Australian Prescriber 45 (2), 67, 2022 | 2 | 2022 |
| Avoiding misclassification of acute kidney injury: Timing is everything A Legg, JA Roberts, MA Roberts, A Cass, J Davies, SYC Tong, JS Davis Nephrology 29 (2), 100-104, 2024 | 1 | 2024 |
| Optimal drug therapy for Staphylococcus aureus bacteraemia in adults A Legg, JS Davis, JA Roberts Current Opinion in Critical Care 29 (5), 446-456, 2023 | 1 | 2023 |
| Longer-term Mortality and Kidney Outcomes of Participants in the Combination Antibiotics for Methicillin-Resistant Staphylococcus aureus (CAMERA2) Trial: A Post … A Legg, MA Roberts, J Davies, A Cass, N Meagher, A Sud, V Daitch, ... Open forum infectious diseases 10 (7), ofad337, 2023 | 1 | 2023 |
| The MOBILISE study: utilisation of ambulatory pumps in the inpatient setting to administer continuous antibiotic infusions—a randomised controlled trial KL McCarthy, T Harris-Brown, EJ Smits, A Legg, MD Chatfield, ... European Journal of Clinical Microbiology & Infectious Diseases 40, 2505-2513, 2021 | 1 | 2021 |
| Declining soil transmitted helminth detections in an Australian tropical region S Janson, P Smith, A Legg, RW Baird Pathology 51 (7), 737-741, 2019 | 1 | 2019 |
| The Australasian Registry for Severe Cutaneous Adverse Reactions (AUS-SCAR)–Providing a roadmap for closing the diagnostic, patient, and healthcare gaps for a group of rare … F James, MS Goh, S Vogrin, I Ng, AP Douglas, NE Holmes, KYL Chua, ... World Allergy Organization Journal 17 (8), 100936, 2024 | | 2024 |
| Sotrovimab Use in Young Pediatric Patients at High Risk of Progression to Severe COVID-19 Disease E White, A Legg, A Bogart, N Graham, F Jebreen, JE Clark Journal of the Pediatric Infectious Diseases Society 12 (4), 242-245, 2023 | | 2023 |
| Correction to: Risk Factors for Nephrotoxicity in Methicillin-Resistant Staphylococcus aureus Bacteraemia: A Post Hoc Analysis of the CAMERA2 Trial A Legg, N Meagher, SA Johnson, MA Roberts, A Cass, MH Scheetz, ... Clinical Drug Investigation 43 (1), 35, 2023 | | 2023 |
| HepatoCare model of multi-disciplinary supportive and palliative care in advanced cirrhosis: A study of post-pilot real world performance N Tiwari, O Cullen, A Kearney, A Legg, I Arbi, C Douglas, B Leggett, ... JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 36, 52-52, 2021 | | 2021 |
